Detalles de la búsqueda
1.
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Osteoporos Int
; 34(8): 1283-1299, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37351614
2.
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
Calcif Tissue Int
; 112(2): 197-217, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633611
3.
Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
Aging Clin Exp Res
; 35(8): 1581-1593, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219755
4.
Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach.
Aging Clin Exp Res
; 34(9): 1985-1995, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864304
5.
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.
Aging Clin Exp Res
; 34(11): 2603-2623, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36287325
6.
Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.
Aging Clin Exp Res
; 33(1): 3-17, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32737844
7.
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.
Calcif Tissue Int
; 105(2): 125-126, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338562
8.
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.
Calcif Tissue Int
; 105(2): 109-124, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31098729
9.
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Aging Clin Exp Res
; 31(7): 905-915, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993659
10.
Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
Calcif Tissue Int
; 113(3): 357-358, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488204
11.
Medicines for an aging population: The EMA perspective and policies.
J Am Geriatr Soc
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38757979
12.
Evidence-Based Guideline for the management of osteoporosis in men.
Nat Rev Rheumatol
; 20(4): 241-251, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485753
13.
Quality of life in sarcopenia and frailty.
Calcif Tissue Int
; 93(2): 101-20, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23828275
14.
Assessing Medicines for Use in the Geriatric Population.
Clin Pharmacol Ther
; 113(3): 536-540, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36354419
15.
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults.
Lancet Healthy Longev
; 4(12): e724-e729, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977177
16.
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.
Nat Rev Endocrinol
; 18(6): 366-384, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484227
17.
Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations.
Drugs
; 82(13): 1347-1355, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112341
18.
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
Clin Pharmacol Ther
; 110(5): 1311-1317, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472087
19.
Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.
ESMO Open
; 4(6): e000550, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31798977
20.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Adv Ther
; 36(10): 2811-2824, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440982